These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hormone replacement therapy in women with a history of breast cancer. Ylikorkala O, Metsä-Heikkilä M. Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034 [Abstract] [Full Text] [Related]
8. Effects of hormone replacement therapy on mammographic findings. Bülbül NH, Ozden S, Dayicioglu V. Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467 [Abstract] [Full Text] [Related]
9. Options for hormone therapy in women who have had a hysterectomy. Haney AF, Wild RA. Menopause; 2007 Apr; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150 [Abstract] [Full Text] [Related]
10. [Reasons for abandonment of hormone replacement therapy with tibolone in menopausal women]. Zayas-Jaime FJ, Ornelas-Aguirre JM, Pérez-Nápoles DE. Ginecol Obstet Mex; 2013 Oct; 81(10):593-601. PubMed ID: 24483042 [Abstract] [Full Text] [Related]
11. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Kenemans P, Speroff L, International Tibolone Consensus Group. Maturitas; 2005 May 16; 51(1):21-8. PubMed ID: 15883105 [Abstract] [Full Text] [Related]
13. Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature. Zanello M, Borghese G, Manzara F, Degli Esposti E, Moro E, Raimondo D, Abdullahi LO, Arena A, Terzano P, Meriggiola MC, Seracchioli R. Medicina (Kaunas); 2019 Aug 14; 55(8):. PubMed ID: 31416164 [Abstract] [Full Text] [Related]
14. Tibolone: a unique version of hormone replacement therapy. Swegle JM, Kelly MW. Ann Pharmacother; 2004 May 14; 38(5):874-81. PubMed ID: 15026563 [Abstract] [Full Text] [Related]
15. Hormone replacement therapy use and variations in the risk of breast cancer. Opatrny L, Dell'Aniello S, Assouline S, Suissa S. BJOG; 2008 Jan 14; 115(2):169-75; discussion 175. PubMed ID: 18081598 [Abstract] [Full Text] [Related]
16. The role of hormone replacement therapy in endometrial polyp formation. Oguz S, Sargin A, Kelekci S, Aytan H, Tapisiz OL, Mollamahmutoglu L. Maturitas; 2005 Mar 14; 50(3):231-6. PubMed ID: 15734604 [Abstract] [Full Text] [Related]
17. Postmenopausal hormone therapy and the risk of cardiovascular disease. Stramba-Badiale M. J Cardiovasc Med (Hagerstown); 2009 Apr 14; 10(4):303-9. PubMed ID: 19430340 [Abstract] [Full Text] [Related]
18. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Chang SC, Lacey JV, Brinton LA, Hartge P, Adams K, Mouw T, Carroll L, Hollenbeck A, Schatzkin A, Leitzmann MF. Cancer Epidemiol Biomarkers Prev; 2007 Apr 14; 16(4):723-30. PubMed ID: 17416763 [Abstract] [Full Text] [Related]
19. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Campisi R, Marengo FD. Cardiovasc Drug Rev; 2007 Apr 14; 25(2):132-45. PubMed ID: 17614936 [Abstract] [Full Text] [Related]
20. [Historical perspective of hormone replacement therapy]. Chanson P. Rev Prat; 2005 Feb 28; 55(4):369-75. PubMed ID: 15828614 [Abstract] [Full Text] [Related] Page: [Next] [New Search]